Financial calendar 2016/17

Hoersholm, 2016-08-30 16:19 CEST (GLOBE NEWSWIRE) --  

Company announcement No. 12 / 2016

2016

26 October              Annual Report 2015/16

29 November           Annual General Meeting

Please note that proposals which shareholders wish to be addressed at the Annual General Meeting will be added to the agenda if such a request is submitted to the Board of Directors no later than on Monday, 17 October 2016.

2017

11 January              Interim Report (Q1 2016/17)

6 April                    Interim Report (Q2 2016/17)

29 June                  Interim Report (Q3 2016/17)

25 October              Annual Report 2016/17

28 November           Annual General Meeting

Please note that proposals which shareholders wish to be addressed at the Annual General Meeting will be added to the agenda if such a request is submitted to the Board of Directors no later than on Monday, 16 October 2017.

For further information, please contact:

Anders Mohr Christensen, Senior Director, Investor Relations
Tel: +45 4574 7618

The announcement has been prepared in Danish and in English. In the event of discrepancies, the Danish version prevails.

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2014/15 financial year was EUR 859 million. The company has more than 2,600 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen. For further information, please visit www.chr-hansen.com.

Vedhæftede filer:

No 12 2016 US.pdf